News

Hesai Group's Upcoming Q3 2025 Financial Results Announcement

Hesai Group's Upcoming Q3 2025 Financial Results Announcement

Hesai Group to Announce Third Quarter 2025 Financial Results

Hesai Group, a global leader in lidar technology, has made a significant announcement concerning its upcoming third quarter 2025 financial results. The company is set to reveal these results before the market opens on November 11, 2025. Investors and analysts alike are keenly awaiting this disclosure to gauge the company's progress and market standing.

Details of the Earnings Conference Call

To elaborate on the results, the company plans to host an earnings conference call at 7:00 AM U.S. Eastern Time on the same day. This call provides an invaluable opportunity for stakeholders to hear the company's insights directly from management. Hesai encourages participants to pre-register for the call to facilitate a smooth joining experience.

Joining the Conference Call

Participants looking to join the call are advised to complete the pre-registration. They should dial in five minutes before the scheduled start time. Upon successful registration, participants will receive essential dial-in details.

Webcast Availability

In today's digital age, Hesai is committed to accessibility. A live and archived webcast of the conference call will be available on the company’s investor relations website, ensuring that those unable to attend the live session can still access the information shared during the call.

Replay of the Earnings Call

For those who cannot join the call live, a replay will be accessible approximately an hour after the conclusion of the call, remaining available until November 18, 2025. Interested parties can use specific telephone numbers for access, helping ensure everyone can stay updated on the company's performance.

Global Contact Numbers

The call replay will cater to international audiences with various local numbers. For the United States, the number is +1-855-883-1031, while international participants can dial +61-7-3107-6325. Residents of Hong Kong can use the local number 800-930-639, and those in mainland China can access the call using 400-120-9216. The replay PIN is 10050816 for easy access.

About Hesai Technology

Founded as a leader in the lidar solutions market, Hesai Technology provides cutting-edge products that facilitate numerous applications across various sectors, including advanced driver assistance systems (ADAS) and autonomous vehicles. Their innovative lidar systems are not just limited to automotive use; they extend to robotics, aiding in applications such as last-mile delivery.

Hesai is committed to integrating its manufacturing processes with in-house R&D efforts. This unique approach allows for rapid product development while ensuring both performance and affordability. Such attributes have solidified the company's reputation, supported by a robust team that specializes in optics, mechanics, and electronics.

Global Presence

With offices in major cities such as Shanghai, Palo Alto, and Stuttgart, Hesai Group boasts a diverse clientele across over 40 countries. This international footprint emphasizes their ability to meet varied market needs and adapt to unique challenges presented by different regions.

Investor Inquiries

For inquiries regarding financial matters or media contacts, interested parties can reach out to Yuanting "YT" Shi, Head of Capital Markets at Hesai, via email at ir@hesaitech.com. For further assistance, Christensen Advisory can also be contacted at +86-10-5900-1548 or through their email hesai@christensencomms.com.

Frequently Asked Questions

1. When will Hesai Group report its Q3 2025 results?

Hesai Group plans to announce its Q3 2025 financial results on November 11, 2025, before market opening.

2. How can I participate in the earnings conference call?

Participants can pre-register for the conference call by accessing the registration link provided in company communications. It's advisable to dial in five minutes early.

3. Is there a way to listen to the earnings call later?

Yes, a replay of the earnings call will be available starting about an hour after it ends, accessible until November 18, 2025.

4. What products does Hesai Group specialize in?

Hesai specializes in lidar solutions for ADAS, autonomous vehicles, and robotics, among other applications.

5. Who can I contact for media inquiries?

For media inquiries, you can contact Yuanting "YT" Shi at Hesai Group or reach out to Christensen Advisory for further assistance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading